Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response

Revision as of 01:56, 7 February 2026 by Nhmkerala (talk | contribs) (Created paper page - 2026-02-07T07:26:34.751539)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Authors: Sol Kim, Hyolim Kang, Laura Skrip, Sushant Sahastrabuddhe, Ausraful Islam, Sung-Mok Jung, Juan F. Vesga, Akira Endo, W. John Edmunds, Kaja Abbas

Year: 2025

Journal: Expert Review of Vaccines

DOI: 10.1080/14760584.2025.2476523

Summary

This paper reviews the progress and challenges in developing vaccines for Nipah virus, a high-consequence pathogen with no available vaccines or therapeutics.

Methodology

  • Study Type: Perspective

Topics

Vaccine Development, Nipah Virus

Relevance

This paper is important for understanding the challenges in developing vaccines against Nipah virus, which can aid in preparedness and response efforts.

Source

View the entire paper: File:Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response.pdf